tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

MXCT Stock Latest News

MaxCyte Announces Change in Major Holdings by BlackRock
Company AnnouncementsMaxCyte Announces Change in Major Holdings by BlackRock
1d ago
MXCT
BlackRock Increases Stake in MaxCyte, Inc.
PremiumCompany Announcements
BlackRock Increases Stake in MaxCyte, Inc.
3d ago
MXCT
MaxCyte sees FY24 revenue $32.2M-$32.4M, consensus $37.9M
PremiumThe Fly
MaxCyte sees FY24 revenue $32.2M-$32.4M, consensus $37.9M
6d ago
MXCT
MaxCyte sees Q4 revenue $8.3M-$8.5M, consensus $7.67M
PremiumThe Fly
MaxCyte sees Q4 revenue $8.3M-$8.5M, consensus $7.67M
6d ago
MXCT
MaxCyte Reports 2024 Financial Growth and Industry Milestones
PremiumCompany Announcements
MaxCyte Reports 2024 Financial Growth and Industry Milestones
6d ago
MXCT
MaxCyte Expands Common Stock Issuance to 105.7 Million Shares
PremiumCompany AnnouncementsMaxCyte Expands Common Stock Issuance to 105.7 Million Shares
16d ago
MXCT
MaxCyte Director Exercises Stock Options and Executes Sales
Premium
Company Announcements
MaxCyte Director Exercises Stock Options and Executes Sales
19d ago
MXCT
MaxCyte Announces Leadership Transition and Strategic Focus
Premium
Company Announcements
MaxCyte Announces Leadership Transition and Strategic Focus
22d ago
8K
MXCT
MaxCyte Announces Board Member Retirement
PremiumCompany Announcements
MaxCyte Announces Board Member Retirement
27d ago
MXCT
MaxCyte Announces Change in Shareholder Voting Rights Due to BlackRock Holdings
PremiumCompany Announcements
MaxCyte Announces Change in Shareholder Voting Rights Due to BlackRock Holdings
1M ago
MXCT
BlackRock Adjusts Stake in MaxCyte, Influencing Voting Rights
PremiumCompany Announcements
BlackRock Adjusts Stake in MaxCyte, Influencing Voting Rights
1M ago
MXCT
MaxCyte, Inc. Announces Change in Major Holdings by BlackRock
PremiumCompany Announcements
MaxCyte, Inc. Announces Change in Major Holdings by BlackRock
1M ago
MXCT
MaxCyte Announces Change in Major Shareholdings
PremiumCompany AnnouncementsMaxCyte Announces Change in Major Shareholdings
1M ago
MXCT
MaxCyte to reduce workforce by 15% following internal review
Premium
The Fly
MaxCyte to reduce workforce by 15% following internal review
1M ago
MXCT
MaxCyte raises FY24 core business revenue view to 6%-8% from flat to up 5%
Premium
The Fly
MaxCyte raises FY24 core business revenue view to 6%-8% from flat to up 5%
1M ago
MXCT
MaxCyte Streamlines Workforce and Boosts Revenue Outlook
PremiumCompany Announcements
MaxCyte Streamlines Workforce and Boosts Revenue Outlook
1M ago
MXCT
MaxCyte Expands Stock Capital Amid Cell Therapy Growth
PremiumCompany Announcements
MaxCyte Expands Stock Capital Amid Cell Therapy Growth
2M ago
MXCT
MaxCyte’s Voting Rights Shift with BlackRock Acquisition
PremiumCompany Announcements
MaxCyte’s Voting Rights Shift with BlackRock Acquisition
2M ago
MXCT
MaxCyte Sees Shift in BlackRock’s Shareholding
PremiumCompany Announcements
MaxCyte Sees Shift in BlackRock’s Shareholding
2M ago
MXCT
MaxCyte Weighs Delisting from AIM to Prioritize Nasdaq: Potential Benefits and Risks Ahead
PremiumCompany AnnouncementsMaxCyte Weighs Delisting from AIM to Prioritize Nasdaq: Potential Benefits and Risks Ahead
2M ago
MXCT
MaxCyte’s Revenue Grows and Strategic Moves Unveiled
Premium
Company Announcements
MaxCyte’s Revenue Grows and Strategic Moves Unveiled
2M ago
MXCT
MaxCyte Files Quarterly Report, Highlights Financial Progress
Premium
Company Announcements
MaxCyte Files Quarterly Report, Highlights Financial Progress
2M ago
MXCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >